Story · Medicine & Biotech · Public Health

STAT+: Amgen’s Repatha linked to fewer heart attacks

1 outlet · first reported by STAT Biotech 5d ago

Coverage, in order

  1. 5d ago
    STAT Biotech indie study observational
    STAT+: Amgen’s Repatha linked to fewer heart attacks

    Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Pithy intro text about the biopharma milieu. Novartis cites more tumor reports after Zolgensma Novartis has disclosed seven previously unreported cases of tumors in children…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.